Medication to improve lungs and muscles in COPD
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Lungs & breathing clinical trials.
This study tests whether a weekly injection called tirzepatide can help people with COPD (chronic lung disease) breathe better and maintain muscle strength. It may also help with weight-related health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 to 80 years old.
- You have been diagnosed with COPD (chronic obstructive pulmonary disease).
- You are a former smoker with a smoking history of at least 10 pack-years (e.g., 1 pack a day for 10 years).
- Your body mass index (BMI) is 27 or higher, with a weight-related condition like high blood pressure, high cholesterol, or sleep apnea, or your BMI is between 30 and 40.
- You are not currently taking certain medications like oral steroids or testosterone, and you haven't had a COPD flare-up in the last 60 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether adding a structured exercise program to the weight-loss medication tirzepatide can improve muscle health and physical function in people who are overweight or obese. Participants will exercise while taking their usual medication, and the researchers will measure muscle quality and strength.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the ability to exercise and daily function in people who have heart failure with reduced pumping strength and are overweight or obese.
This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.
This study tests if the drug tirzepatide can improve muscle and blood vessel health in older adults with obesity. You may be eligible if you are 50 or older, have a BMI between 30 and 40, and do not have diabetes.
This study tests whether tirzepatide, a medication for weight management, affects muscle health in women with obesity. It may help if you are looking for a treatment that preserves muscle while losing weight.
This study tests a medication called tirzepatide (a type of GLP-1 drug) to see how it affects muscle and bone health during weight loss. It is for people with obesity who are not menopausal and do not have diabetes or bone disease.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.